Keyphrases
Androgen Receptor
14%
Anti-prostate Cancer
42%
Anticipated Outcomes
28%
Antiparasitic Drugs
28%
Approved Drugs
14%
Cancer Activity
42%
Cancer Causes
14%
Cancer Mortality
14%
Castration-resistant Prostate Cancer
100%
Cell Culture
14%
Chemical Compounds
14%
Clinical Testing
14%
Clinically Significant
14%
Critical Energy
14%
Culture in Vitro
14%
Deprivation
14%
Diarrhea
14%
Drug Screening
14%
Enzalutamide
14%
Generative Process
14%
Hormone Production
14%
Hormone Receptor
14%
Hormone Therapy
42%
Male Hormones
42%
Metabolic Targets
100%
Metastasis
14%
Molecular Mechanism
14%
Mouse Model
14%
Nitazoxanide
100%
Novel Therapies
100%
Patient Survival
14%
Patients with Cancer
14%
Prostate Cancer
85%
Prostate Cancer Cells
57%
Prostate Cancer Patients
14%
Rapid Development
14%
Resistant Prostate Cancer
42%
Resume
14%
S-phase Kinase-associated Protein 2 (Skp2)
100%
Safety Profile
28%
Selling
14%
Skin Cancer
14%
Therapy Resistance
14%
Therapy Treatment
14%
Therapy-resistant
42%
Treatment Options
14%
United States
14%
Medicine and Dentistry
Androgen Receptor
6%
Antiparasitic Agent
12%
Cancer Cell
25%
Cancer Mortality
6%
Castration Resistant Prostate Cancer
100%
Diarrhea
6%
Disease
12%
Drug Screening
6%
Enzalutamide
6%
Hormone Receptor
6%
Hormone Synthesis
6%
Hormone Therapy
18%
In Vitro
6%
Metastatic Carcinoma
6%
Nitazoxanide
50%
Parasite (Microbiology)
6%
Prostate Cancer
100%
Skin Cancer
6%
Therapy Resistance
6%
Pharmacology, Toxicology and Pharmaceutical Science
Androgen Receptor
6%
Antiparasitic Agent
12%
Cancer Mortality
6%
Castration Resistant Prostate Cancer
100%
Diarrhea
6%
Disease
12%
Disseminated Cancer
6%
Drug Screening
6%
Endocrine Therapy
18%
Enzalutamide
6%
Hormone Receptor
6%
Mouse Model
6%
Nitazoxanide
50%
Prostate Cancer
100%
Skin Cancer
6%
Therapy Resistance
6%